Literature DB >> 27033239

Endotoxemia as a trigger of thrombosis in cirrhosis.

Francesco Violi1, Gregory Y H Lip2, Roberto Cangemi3.   

Abstract

Entities:  

Keywords:  cirrhosis; endotoxemia; thrombosis

Mesh：

Substances：

Year:  2016        PMID： 27033239      PMCID： PMC5004387          DOI： 10.3324/haematol.2015.139972

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  10 in total

1.  von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

Authors:  Monika Ferlitsch; Thomas Reiberger; Matthias Hoke; Petra Salzl; Bernadette Schwengerer; Gregor Ulbrich; Berit Anna Payer; Michael Trauner; Markus Peck-Radosavljevic; Arnulf Ferlitsch
Journal:  Hepatology       Date:  2012-08-27       Impact factor: 17.425

2.  Enhanced expression of monocyte tissue factor in patients with liver cirrhosis.

Authors:  M Saliola; R Lorenzet; D Ferro; S Basili; C Caroselli; A D Santo; M Sallese; F Violi
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 3.  The coagulopathy of chronic liver disease.

Authors:  Armando Tripodi; Pier Mannuccio Mannucci
Journal:  N Engl J Med       Date:  2011-07-14       Impact factor: 91.245

4.  Should the term coagulopathy in cirrhosis be abandoned?

Authors:  Francesco Violi
Journal:  JAMA Intern Med       Date:  2015-05       Impact factor: 21.873

Review 5.  The role of intestinal endotoxin in liver injury: a long and evolving history.

Authors:  James P Nolan
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

6.  Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study.

Authors:  Filipe Nery; Sylvie Chevret; Bertrand Condat; Emmanuelle de Raucourt; Larbi Boudaoud; Pierre-Emmanuel Rautou; Aurelie Plessier; Dominique Roulot; Cendrine Chaffaut; Valerie Bourcier; Jean-Claude Trinchet; Dominique-Charles Valla
Journal:  Hepatology       Date:  2015-01-05       Impact factor: 17.425

7.  Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis.

Authors:  A B Lumsden; J M Henderson; M H Kutner
Journal:  Hepatology       Date:  1988 Mar-Apr       Impact factor: 17.425

8.  Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.

Authors:  K L Moore; S P Andreoli; N L Esmon; C T Esmon; N U Bang
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

Review 9.  Clotting activation and hyperfibrinolysis in cirrhosis: implication for bleeding and thrombosis.

Authors:  Francesco Violi; Domenico Ferro
Journal:  Semin Thromb Hemost       Date:  2013-03-13       Impact factor: 4.180

10.  Factor VIII expression in liver disease.

Authors:  Martine J Hollestelle; Hendrika G M Geertzen; Irene H Straatsburg; Thomas M van Gulik; Jan A van Mourik
Journal:  Thromb Haemost       Date:  2004-02       Impact factor: 5.249
  10 in total
  2 in total

1.  Serum lipopolysaccharides predict advanced liver disease in the general population.

Authors:  Ville Männistö; Martti Färkkilä; Pirkko Pussinen; Antti Jula; Satu Männistö; Annamari Lundqvist; Liisa Valsta; Veikko Salomaa; Markus Perola; Fredrik Åberg
Journal:  JHEP Rep       Date:  2019-10-23

2.  Increased portal vein diameter is predictive of portal vein thrombosis development in patients with liver cirrhosis.

Authors:  Gang Dong; Xiao-Quan Huang; Yu-Li Zhu; Hong Ding; Feng Li; Shi-Yao Chen
Journal:  Ann Transl Med       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.